Hinduism allows Hadiya’s father to kill her and go to jail: Saffron leader

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, May 12: Karnataka sees the highest single day spike since the start of the pandemic in the state, higher than Sunday's spike in cases. 63 new cases have been reported in last 24 hours. 

With this, the total number of COVID-19 cases rises to 925, said the state health department's bulletin on Tuesday.

While 42 new positive cases reported from May 11, 5 pm to May 12, noon, another 21 fresh 21 cases reported by 5 pm on May 12.

To date, 921 COVID-19 positive cases have been confirmed. This includes 31 deaths and 426 discharged," the bulletin read further.

Morning Bulletin

New cases in Bengaluru Urban 3,  Yadgir 2, Bagalkote 15, Dakshina Kannada 2, Dharwad 9, Bidar 2, Hassan 5, Ballari, Mandya, Chikkaballapura, Kalaburagi (one each).  

Evening Bulletin

Cases in Gadag (3), Kolar (5), Bengaluru Urban (1) and Davangere (11) cases. 

Cases reported on 12 May: 63

Total cases in state: 925
 

Bengaluru, May 17: At least 54 new COVID-19 positive cases have emerged since last evening, raising Karnataka's tally to 1,146, a health official said today.

Among the 1,146 cases, 611 are active and isolated in designated hospitals across the state, 497 patients got discharged and 37 died of the virus.

Of the new cases, Mandya district alone reported 22 cases, followed by 10 in Kalaburgi, 6 in Hassan, 4 in Dharward, 3 each in Kolar and Yadgir, 2 each in Dakshina Kannada and Shivamogga and 1 each in Udupi and Shivamogga.

New Cases Reported: 54
Total Active Cases: 611
Total Discharges: 497
Total Covid Deaths: 37
Death of Covid +ve patient due to Non-Covid cause: 1
Total Positive Cases: 1146